Description
MPG 1/2 Tablets – Glimepiride + Metformin SR + Pioglitazone
Key Benefits:
- Glimepiride: Lowers blood sugar by stimulating insulin secretion from pancreatic beta cells.
- Metformin: Reduces hepatic glucose production and improves insulin sensitivity.
- Pioglitazone: Reduces insulin resistance, increases hepatic glucose disposal, and improves both first and second phase insulin secretion.
Why MPG 1/2?
- Effective triple therapy for patients uncontrolled on mono or dual therapy.
- Targets multiple pathways for comprehensive diabetes control.
- Helps achieve steady sugar levels and prevents long-term complications.
Indications:
- Type 2 Diabetes Mellitus
- Metabolic Syndrome
- Insulin Resistance Syndrome
Tagline:
Strong Trio, Steady Sugar.
